Humedix Co., Ltd. (200670.KQ)

KRW 40750.0

(1.75%)

Long Term Debt Summary of Humedix Co., Ltd.

Humedix Co., Ltd.'s latest annual long term debt in 2023 was 1.75 Billion KRW , down -27.97% from previous year.
Humedix Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 1.39 Billion KRW , down 0.0% from previous quarter.
Humedix Co., Ltd. reported annual long term debt of 2.43 Billion KRW in 2022, down -91.76% from previous year.
Humedix Co., Ltd. reported annual long term debt of 29.57 Billion KRW in 2021, up 11472.7% from previous year.
Humedix Co., Ltd. reported quarterly long term debt of 1.39 Billion KRW for 2024 Q2, down 0.0% from previous quarter.
Humedix Co., Ltd. reported quarterly long term debt of 1.87 Billion KRW for 2023 Q3, down -9.87% from previous quarter.

Annual Long Term Debt Chart of Humedix Co., Ltd. (2023 - 2015)

Historical Annual Long Term Debt of Humedix Co., Ltd. (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	1.75 Billion KRW	-27.97%
2022	2.43 Billion KRW	-91.76%
2021	29.57 Billion KRW	11472.7%
2020	255.57 Million KRW	40.71%
2019	181.63 Million KRW	0.0%
2018	- KRW	-100.0%
2017	3.93 Billion KRW	-57.32%
2016	9.22 Billion KRW	0.0%
2015	- KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	1.55 Billion KRW	0.0%
2024 Q2	1.39 Billion KRW	0.0%
2023 Q3	1.87 Billion KRW	-9.87%
2023 FY	1.75 Billion KRW	-27.97%
2023 Q2	2.07 Billion KRW	-7.52%
2023 Q4	1.75 Billion KRW	-6.15%
2023 Q1	2.24 Billion KRW	0.0%
2022 FY	2.43 Billion KRW	-91.76%
2022 Q4	- KRW	0.0%
2022 Q3	- KRW	0.0%
2022 Q2	- KRW	-100.0%
2022 Q1	30.27 Billion KRW	2.38%
2021 FY	29.57 Billion KRW	11472.7%
2021 Q3	33.05 Billion KRW	1.76%
2021 Q4	29.57 Billion KRW	-10.52%
2021 Q2	32.48 Billion KRW	13354317.89%
2021 Q1	243.25 Thousand KRW	-4.82%
2020 Q3	256.56 Thousand KRW	-13.42%
2020 FY	255.57 Million KRW	40.71%
2020 Q4	255.57 Thousand KRW	-0.38%
2020 Q1	213.48 Thousand KRW	17.53%
2020 Q2	296.31 Thousand KRW	38.8%
2019 Q4	181.63 Thousand KRW	-1.66%
2019 FY	181.63 Million KRW	0.0%
2019 Q3	184.71 Thousand KRW	-27.87%
2019 Q2	256.07 Thousand KRW	-39.79%
2019 Q1	425.27 Thousand KRW	0.0%
2018 Q3	- KRW	-100.0%
2018 FY	- KRW	-100.0%
2018 Q1	2.62 Million KRW	-33.33%
2018 Q4	- KRW	0.0%
2018 Q2	1.31 Million KRW	-50.0%
2017 FY	3.93 Billion KRW	-57.32%
2017 Q4	3.93 Million KRW	-25.0%
2017 Q1	7.87 Million KRW	-14.63%
2017 Q2	6.56 Million KRW	-16.67%
2017 Q3	5.25 Million KRW	-20.0%
2016 Q4	9.22 Million KRW	0.0%
2016 FY	9.22 Billion KRW	0.0%
2016 Q1	- KRW	0.0%
2015 FY	- KRW	0.0%

Peer Long Term Debt Comparison of Humedix Co., Ltd.

Name	Long Term Debt	Long Term Debt Difference
HLB Pharmaceutical Co., Ltd	988.75 Million KRW	-77.529%
CMG Pharmaceutical Co., Ltd.	19.06 Billion KRW	90.792%
Celltrion Pharm, Inc.	4.33 Billion KRW	59.492%
Huons Global Co., Ltd.	66.94 Billion KRW	97.378%
DongKook Pharmaceutical Co., Ltd.	18.74 Billion KRW	90.638%
Enzychem Lifesciences Corporation	1.02 Billion KRW	-71.252%
Boditech Med Inc.	2.09 Billion KRW	16.411%
EuBiologics Co., Ltd.	2.8 Billion KRW	37.31%
FutureChem Co.,Ltd	2.61 Billion KRW	32.997%
Huons Co., Ltd.	58.35 Billion KRW	96.992%
BNC Korea Co., Ltd.	301.69 Million KRW	-481.832%
AptaBio Therapeutics Inc.	13.56 Billion KRW	87.064%